2026 · Evidence-Ranked
The Peptide Tier List
Not a vibe ranking. Every tier below is anchored to evidence quality — phase-3 trial data, reproducible preclinical effect sizes, and safety signals. The gap between "works in mice and forums" and "works in a controlled human trial" is enormous; we use it as the spine of this list.
SClinically validated · large effect
AEvidence-backed · specific use case
TesamorelinFDA-approved visceral-fat reduction
GHK-Cu (topical)Cosmetic gene-modulation data
LiraglutideFirst GLP-1 approved for obesity
BPromising preclinical · limited human data
BPC-157Rodent tissue-healing strength
TB-500Actin dynamics · tissue repair
CJC-1295 + IpamorelinPulsatile GH amplification
SermorelinGHRH 1-29 — older GHRH analog
CInteresting science · very early
MOTS-cMitokine · AMPK activation
EpitalonPineal bioregulator · telomerase research
RetatrutideTriple agonist · Phase 3 readouts pending
DOverhyped · under-evidenced
AOD-9604Missed Phase 2b weight-loss endpoints
5-Amino-1MQNot a peptide — sparse human data
Methodology note — this list weights published phase-2/3 trial data most heavily, followed by reproducible preclinical data, then mechanism plausibility. Internet popularity, influencer endorsement, and anecdote are not inputs. Updated when meaningful trial readouts publish.